Clinical Trial Update: Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in Asian patients evaluated the safety and response of Fosbretabulin for Polypoidal Choroidal Vasculopathy, and the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Fosbretabulin (fosbretabulin)

Snippet

Sponsor: Mateon Therapeutics | Conditions: Polypoidal Choroidal Vasculopathy | Phase 2 | Status: COMPLETED